Systematic review of genetic polymorphisms associated with psychoneurological symptoms in breast cancer survivors
- 226 Downloads
Psychoneurological (PN) symptoms, such as anxiety, cognitive impairment, depression, fatigue, sleep disturbances, and pain, are highly prevalent in breast cancer patients undergoing cancer treatment. Emerging evidence suggests that genetic polymorphisms may contribute to differential symptom susceptibility. We aimed to systematically review associations between genetic polymorphisms and PN symptoms during or after cancer treatment for early-stage breast cancer.
Twenty-six eligible articles published until October 2017 were identified in PubMed, PsycINFO, Web of Science, and additional records. Information on study characteristics, genetic polymorphisms, and PN symptoms was extracted. Study quality was evaluated by the STrengthening the REporting of Genetic Association (STREGA) guideline. Genes included in the analysis were categorized by biological pathways based on the Reactome database.
A total of 54 single nucleotide polymorphisms and haplotypes that are significantly associated with PN symptoms were identified; half of them were associated with increased severity of PN symptoms, while the other half contributed to the decrease of PN symptoms. Pain has the known highest number of associated genetic polymorphisms reported, followed by fatigue, cognitive impairment, depressive symptoms, sleep disturbances, and anxiety. The majority of genetic polymorphisms were involved in immune system and neuronal system pathways. Most studies were unsuccessful in meeting the STREGA guideline, which requires transparent reporting of methods and results.
This review provides comprehensive evidence of genetic polymorphisms underlying PN symptoms, which may pave the way for the development of personalized therapeutics targeting these symptoms. More well-designed genome-wide association studies are required to validate and replicate these findings.
KeywordsBreast cancer Psychoneurological symptoms Genetic polymorphism Single nucleotide polymorphism Systematic review
We would like to thank Ms. Debra McDonald for proofreading.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
- 1.Alfaro E, Dhruva A, Langford DJ, Koetters T, Merriman JD, West C, Dunn LB, Paul SM, Cooper B, Cataldo J, Hamolsky D, Elboim C, Kober K, Aouizerat BE, Miaskowski C (2014) Associations between cytokine gene variations and self-reported sleep disturbance in women following breast cancer surgery. Eur J Oncol Nurs 18:85–93. https://doi.org/10.1016/j.ejon.2013.08.004 CrossRefPubMedGoogle Scholar
- 6.Cajanus K, Holmstrom EJ, Wessman M, Anttila V, Kaunisto MA, Kalso E (2016) Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer. Pain 157:361–369. https://doi.org/10.1097/j.pain.0000000000000398 CrossRefPubMedGoogle Scholar
- 8.Clayton DG, Walker NM, Smyth DJ, Pask R, Cooper JD, Maier LM, Smink LJ, Lam AC, Ovington NR, Stevens HE, Nutland S, Howson JM, Faham M, Moorhead M, Jones HB, Falkowski M, Hardenbol P, Willis TD, Todd JA (2005) Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet 37:1243–1246CrossRefGoogle Scholar
- 14.Eshragh J, Dhruva A, Paul SM, Cooper BA, Mastick J, Hamolsky D, Levine JD, Miaskowski C, Kober KM (2017) Associations between neurotransmitter genes and fatigue and energy levels in women after breast cancer surgery. J Pain Symptom Manag 53:67–84 e67. https://doi.org/10.1016/j.jpainsymman.2016.08.004 CrossRefGoogle Scholar
- 15.Fernandez-de-las-Peñas C, Fernandez-Lao C, Cantarero-Villanueva I, Ambite-Quesada S, Rivas-Martinez I, del Moral-Avila R, Arroyo-Morales M (2012) Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors. Breast Cancer Res Treat 133:405–412. https://doi.org/10.1007/s10549-011-1757-y CrossRefPubMedGoogle Scholar
- 17.Garcia-Giralt N, Rodriguez-Sanz M, Prieto-Alhambra D, Servitja S, Torres-Del Pliego E, Balcells S, Albanell J, Grinberg D, Diez-Perez A, Tusquets I, Nogues X (2013) Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study. Breast Cancer Res Treat 140:385–395. https://doi.org/10.1007/s10549-013-2638-3 CrossRefPubMedGoogle Scholar
- 19.Kambur O, Kaunisto MA, Tikkanen E, Leal SM, Ripatti S, Kalso EA (2013) Effect of catechol-o-methyltransferase-gene (COMT) variants on experimental and acute postoperative pain in 1,000 women undergoing surgery for breast cancer. Anesthesiology 119:1422–1433. https://doi.org/10.1097/aln.0000000000000013 CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Kim JM, Kim SW, Stewart R, Kim SY, Shin IS, Park MH, Yoon JH, Lee JS, Park SW, Kim YH, Yoon JS (2012) Serotonergic and BDNF genes associated with depression 1 week and 1 year after mastectomy for breast cancer. Psychosom Med 74:8–15. https://doi.org/10.1097/psy.0b013e318241530c CrossRefPubMedGoogle Scholar
- 23.Kober KM, Smoot B, Paul SM, Cooper BA, Levine JD, Miaskowski C (2016) Polymorphisms in cytokine genes are associated with higher levels of fatigue and lower levels of energy in women after breast cancer surgery. J Pain Symptom Manag 52:695–708 e694. https://doi.org/10.1016/j.jpainsymman.2016.04.014 CrossRefGoogle Scholar
- 24.Koleck TA, Bender CM, Sereika SM, Ahrendt G, Jankowitz RC, McGuire KP, Ryan CM, Conley YP (2014) Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer. Oncol Nurs Forum 41:E313–E325. https://doi.org/10.1188/14.onf.e313-e325 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Langford DJ, Paul SM, West CM, Dunn LB, Levine JD, Kober KM, Dodd MJ, Miaskowski C, Aouizerat BE (2015) Variations in potassium channel genes are associated with distinct trajectories of persistent breast pain after breast cancer surgery. Pain 156:371–380. https://doi.org/10.1097/01.j.pain.0000460319.87643.11 CrossRefPubMedGoogle Scholar
- 26.Lengacher CA, Reich RR, Post-White J, Moscoso M, Shelton MM, Barta M, Le N, Budhrani P (2012) Mindfulness based stress reduction in post-treatment breast cancer patients: an examination of symptoms and symptom clusters. J Behav Med 35:86–94. https://doi.org/10.1007/s10865-011-9346-4 CrossRefPubMedGoogle Scholar
- 27.Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–e34. https://doi.org/10.7326/0003-4819-151-4-200908180-00136 CrossRefPubMedGoogle Scholar
- 28.Lintermans A, Van Asten K, Jongen L, Van Brussel T, Laenen A, Verhaeghe J, Vanderschueren D, Lambrechts D, Neven P (2016) Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients. Eur J Cancer 56:31–36. https://doi.org/10.1016/j.ejca.2015.12.013 CrossRefPubMedGoogle Scholar
- 29.Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart AF, Birkett N (2009) Strengthening the Reporting of Genetic Association Studies (STREGA): an extension of the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. J Clin Epidemiol 62:597–608 e594. https://doi.org/10.1016/j.jclinepi.2008.12.004 CrossRefPubMedGoogle Scholar
- 31.Merriman JD, Aouizerat BE, Cataldo JK, Dunn L, Cooper BA, West C, Paul SM, Baggott CR, Dhruva A, Kober K, Langford DJ, Leutwyler H, Ritchie CS, Abrams G, Dodd M, Elboim C, Hamolsky D, Melisko M, Miaskowski C (2014) Association between an interleukin 1 receptor, type I promoter polymorphism and self-reported attentional function in women with breast cancer. Cytokine 65:192–201. https://doi.org/10.1016/j.cyto.2013.11.003 CrossRefPubMedGoogle Scholar
- 33.Miaskowski C, Conley YP, Mastick J, Paul SM, Cooper BA, Levine JD, Knisely M, Kober KM (2017) Cytokine gene polymorphisms associated with symptom clusters in oncology patients undergoing radiation therapy. J Pain Symptom Manag 54:305–316 e303. https://doi.org/10.1016/j.jpainsymman.2017.05.007 CrossRefGoogle Scholar
- 34.Miaskowski C, Elboim C, Paul SM, Mastick J, Cooper BA, Levine JD, Aouizerat BE (2016) Polymorphisms in tumor necrosis factor-alpha are associated with higher anxiety levels in women after breast cancer surgery. Clin Breast Cancer 16:63–71 e63. https://doi.org/10.1016/j.clbc.2014.12.001 CrossRefPubMedGoogle Scholar
- 35.Miclaus K, Wolfinger R, Vega S, Chierici M, Furlanello C, Lambert C, Hong H, Zhang L, Yin S, Goodsaid F (2010) Batch effects in the BRLMM genotype calling algorithm influence GWAS results for the Affymetrix 500K array. Pharmacogenomics J 10:336–346. https://doi.org/10.1038/tpj.2010.36 CrossRefPubMedGoogle Scholar
- 37.Myers JS, Koleck TA, Sereika SM, Conley YP, Bender CM (2017) Perceived cognitive function for breast cancer survivors: association of genetic and behaviorally related variables for inflammation. Support Care Cancer 25:2475–2484. https://doi.org/10.1007/s00520-017-3654-3 CrossRefPubMedPubMedCentralGoogle Scholar
- 39.Ng T, Teo SM, Yeo HL, Shwe M, Gan YX, Cheung YT, Foo KM, Cham MT, Lee JA, Tan YP, Fan G, Yong WS, Preetha M, Loh WJ, Koo SL, Jain A, Lee GE, Wong M, Dent R, Yap YS, Ng R, Khor CC, Ho HK, Chan A (2016) Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer. Neuro-Oncology 18:244–251. https://doi.org/10.1093/neuonc/nov162 CrossRefPubMedGoogle Scholar
- 42.Reyes-Gibby CC, Swartz MD, Yu X, Wu X, Yennurajalingam S, Anderson KO, Spitz MR, Shete S (2013) Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genes. Support Care Cancer 21:3117–3125. https://doi.org/10.1007/s00520-013-1885-5 CrossRefPubMedPubMedCentralGoogle Scholar
- 43.Saad S, Dunn LB, Koetters T, Dhruva A, Langford DJ, Merriman JD, West C, Paul SM, Cooper B, Cataldo J, Hamolsky D, Elboim C, Aouizerat BE, Miaskowski C (2014) Cytokine gene variations associated with subsyndromal depressive symptoms in patients with breast cancer. Eur J Oncol Nurs 18:397–404. https://doi.org/10.1016/j.ejon.2014.03.009 CrossRefPubMedPubMedCentralGoogle Scholar
- 48.Starkweather AR, Lyon DE, Elswick RK Jr, Montpetit AJ, Conley Y, McCain NL (2013) A conceptual model of psychoneurological symptom cluster variation in women with breast cancer: bringing nursing research to personalized medicine. Curr Pharmacogenomics Person Med 11:224–230. https://doi.org/10.2174/18756921113119990004 CrossRefPubMedPubMedCentralGoogle Scholar
- 49.Stephens K, Cooper BA, West C, Paul SM, Baggott CR, Merriman JD, Dhruva A, Kober KM, Langford DJ, Leutwyler H, Luce JA, Schmidt BL, Abrams GM, Elboim C, Hamolsky D, Levine JD, Miaskowski C, Aouizerat BE (2014) Associations between cytokine gene variations and severe persistent breast pain in women following breast cancer surgery. J Pain 15:169–180. https://doi.org/10.1016/j.jpain.2013.09.015 CrossRefPubMedGoogle Scholar
- 50.Stephens KE, Levine JD, Aouizerat BE, Paul SM, Abrams G, Conley YP, Miaskowski C (2017) Associations between genetic and epigenetic variations in cytokine genes and mild persistent breast pain in women following breast cancer surgery. Cytokine 99:203–213. https://doi.org/10.1016/j.cyto.2017.07.006 CrossRefPubMedPubMedCentralGoogle Scholar